These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11098339)

  • 1. Warfarin resistance due to sulfasalazine.
    Teefy AM; Martin JE; Kovacs MJ
    Ann Pharmacother; 2000 Nov; 34(11):1265-8. PubMed ID: 11098339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential interaction between warfarin and atovaquone.
    Hidalgo K; Lyles A; Dean SR
    Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between warfarin and nafcillin: case report and review of the literature.
    Kim KY; Frey RJ; Epplen K; Foruhari F
    Pharmacotherapy; 2007 Oct; 27(10):1467-70. PubMed ID: 17896903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case report of warfarin resistance due to azathioprine and review of the literature.
    Havrda DE; Rathbun S; Scheid D
    Pharmacotherapy; 2001 Mar; 21(3):355-7. PubMed ID: 11253860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful use of rivaroxaban in postoperative deep vein thrombosis of the lower limb following instability with warfarin: a case report.
    Schiavoni M; Coluccia A
    J Med Case Rep; 2016 Oct; 10(1):276. PubMed ID: 27716428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential interaction involving warfarin and ritonavir.
    Knoell KR; Young TM; Cousins ES
    Ann Pharmacother; 1998 Dec; 32(12):1299-302. PubMed ID: 9876810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient case: impact of smoking cessation on international normalized ratio.
    Jordan SD; Stone MD; Alexander E; Haley J; McKee A
    J Pharm Pract; 2014 Oct; 27(5):470-3. PubMed ID: 24395009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A probable interaction between warfarin and the antiretroviral TRIO study regimen.
    Liedtke MD; Vanguri A; Rathbun RC
    Ann Pharmacother; 2012 Nov; 46(11):e34. PubMed ID: 23115227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy and safety of acenocoumarol and warfarin therapy in patients with lower limb deep vein thrombosis].
    Bernát SI; Rókusz L
    Orv Hetil; 2012 May; 153(20):786-90. PubMed ID: 22580505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of carbamazepine initiation and discontinuation on antithrombotic control in a patient receiving warfarin: case report and review of the literature.
    Parrish RH; Pazdur DE; O'donnell PJ
    Pharmacotherapy; 2006 Nov; 26(11):1650-3. PubMed ID: 17064211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of a clinically significant interaction between warfarin and intravesical gemcitabine.
    Kurtzhalts K; Gee ME; Feuz L; Krajewski KC
    Am J Health Syst Pharm; 2016 Oct; 73(19):1508-11. PubMed ID: 27646812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribers' behavior following below- versus above-range international normalized ratio values in warfarin-treated deep vein thrombosis patients.
    Raut MK; Nelson WW; Wang SW; Coleman CI; Lu L; Patel D; Schein JR; Xiang J; Damaraju CV
    Curr Med Res Opin; 2016 Jul; 32(7):1213-5. PubMed ID: 26960249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malabsorption-associated warfarin resistance.
    Sabol BJ; Basa RR; Wilkins CE
    Am J Health Syst Pharm; 2009 Sep; 66(17):1548-53. PubMed ID: 19710438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide and warfarin interaction: case report and review of the literature.
    Chonlahan J; Halloran MA; Hammonds A
    Pharmacotherapy; 2006 Jun; 26(6):868-71. PubMed ID: 16716139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of sulphasalazine potentiating the hypoprothombinemic effect of warfarin resulting in bleeding.
    Hall S; Rindone JP
    J Clin Pharm Ther; 2011 Apr; 36(2):246-8. PubMed ID: 21366655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
    Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W;
    N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bosentan and warfarin interaction.
    Murphey LM; Hood EH
    Ann Pharmacother; 2003; 37(7-8):1028-31. PubMed ID: 12841813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prednisone on the International Normalized Ratio.
    Stading JA; Chock A; Faulkner MA; Skrabal MZ
    Am J Health Syst Pharm; 2006 Dec; 63(23):2354-6. PubMed ID: 17106008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of deep vein thrombosis with oral anticoagulants in patients with malignancy: prospective cohort study.
    Vucić N; Ostojić R; Svircić T
    Croat Med J; 2002 Jun; 43(3):296-300. PubMed ID: 12035135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.